Unravel Health develops a non-invasive biosensor that measures hormone levels in saliva in near real time.
Unravel Health has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Unravel Health's investors include Leo Capital, Zinc, Hermesa, Embryo Ventures, The Conduit EIS Impact Fund.
Unravel Health is headquartered in London, United Kingdom.
Unravel Health develops a non-invasive biosensor that measures hormone levels in saliva in near real time.
Unravel Health is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Unravel Health — Funding & Investors." VCBacked, October 16, 2026, https://www.vcbacked.co/company/unravel-health. Accessed November 4, 2026.
VCBacked. (2026). Unravel Health — Funding & Investors. Retrieved November 4, 2026, from https://www.vcbacked.co/company/unravel-health
{{cite web |title=Unravel Health — Funding & Investors |url=https://www.vcbacked.co/company/unravel-health |website=VCBacked |access-date=November 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Unravel Health? Request a listing update